Form 4: Vericel Corp: Karen Mahoney, Chief Human Resources Officer, Reports Stock Option Grant

Karen Mahoney, Chief Human Resources Officer of Vericel Corp, reports the acquisition of stock options.

Summary

• Karen Mahoney, the Chief Human Resources Officer of Vericel Corp, filed a Form 4 with the SEC.
• The filing reports the grant of stock options to Mahoney on February 20, 2025.
• Mahoney acquired 12,938 stock options with an exercise price of $54.31.
• The options vest in equal quarterly installments over four years, beginning February 20, 2025, and expire on February 20, 2035.
• Following the transaction, Mahoney directly owns 12,938 derivative securities.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing related to executive compensation. It doesn't contain information that would significantly impact investor sentiment positively or negatively.

Positives

• The grant of stock options aligns the executive's interests with those of the shareholders.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance.

Industry Context

Stock option grants are a common form of executive compensation in the biotechnology industry, used to incentivize performance and retain key personnel.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages in publicly traded companies, particularly in the biotech sector.
• The vesting schedule of four years with quarterly installments is also a common practice.
• Comparing the size of the grant to similar companies and executive roles would require further benchmarking data.

Key Dates

Keywords

Form 4, stock options, insider trading, Vericel Corp, Karen Mahoney, VCEL, Chief Human Resources Officer